Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

Beehive extracts may help with anxiety, depression, and inflammation.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Targeting ornithine decarboxylase can help prevent skin cancer.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The combination of encorafenib and binimetinib caused few skin issues.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Scalp cooling does not stop hair loss from radiotherapy.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Cetuximab can cause eyelash growth, which is rare but manageable.

Biological therapy boosts the immune system to effectively fight melanoma.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.